Qilu Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is SOLIFENACIN SUCCINATE (NON-STERILE, API), with a corresponding US DMF Number 29503.
Remarkably, this DMF maintains an Active status since its submission on June 15, 2015, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 13, 2015, and payment made on July 21, 2015, indicating their dedication to facilitating drug approvals, Categorized as Type II